CMC Drug Product Consulting ApS

CVR 38817566 · Private limited company (ApS) · Active · Low risk

CMC Drug Product Consulting ApS is a Private limited company (ApS), founded on , based in Hvidovre. The company is registered in the industry anden teknisk rådgivning. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 8 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 692k and a net result of DKK 49k.

Bankruptcy risk for CMC Drug Product Consulting ApS

0.1%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 27% of active Danish companies

Lowest riskHighest risk

Increases the risk

Time at current address1 yrs · bankruptcy rate 14.0%1.6×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Number of CEOs0 · bankruptcy rate 12.7%1.4×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
CEOs in total (historical)0 · bankruptcy rate 12.4%1.4×
Website registeredYes · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Annual reports filed late1 · bankruptcy rate 11.3%1.3×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
Return on assets5%–15% · bankruptcy rate 3.5%0.39×
Gross profit growth-10%–0% · bankruptcy rate 4.3%0.49×
Share of late annual reports0.01%–25% · bankruptcy rate 4.5%0.51×
Negative equityNo · bankruptcy rate 5.1%0.58×
Loss for the yearNo · bankruptcy rate 5.3%0.60×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
38817566
Status
Active
Company type
Private limited company (ApS)
Founded
(9 years)
Address
Sønderkær 29
2650 Hvidovre
Municipality
Hvidovre
Industry
Anden teknisk rådgivning (711290)
Bankruptcies in the industry: Rådgivende ingeniørvirksomhed inden for byggeri og anlægsarbejder
Share capital
DKK 40k
Auditor
MunkStrunge
Audit opted out
Yes

Warning signs

Annual reports filed late1 of 8
Missing annual reportNo
Negative equityNo
Equity ratio75.8%
Current ratio414%
Moves (last 2 years)1
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address0
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 1.4mDKK 1.5m
Net profitDKK 49kDKK 82k
EquityDKK 692kDKK -381k
Total assetsDKK 913kDKK 836k
CashDKK 480k–
Short-term debtDKK 221k–
Avg. employees2–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · MunkStrunge.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 202568
1 Jan 2024 – 31 Dec 2024101
1 Jan 2023 – 31 Dec 2023149
1 Jan 2022 – 31 Dec 202231
1 Jan 2021 – 31 Dec 202148
1 Jan 2020 – 31 Dec 202021
1 Jan 2019 – 31 Dec 2019105
26 Jul 2017 – 31 Dec 2018211 Late

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
Owner (100%)TSMF Holding ApSCurrent
FounderTSMF Holding ApSCurrent

Address history (4 moves)

Sønderkær 29, 2650 Hvidovre
Gammel Køge Landevej 283A, 2650 Hvidovre
Bækkeskovvej 5, 2665 Vallensbæk Strand
Stationsparken 26, 2600 Glostrup
Trekronergade 126A, st., 2500 Valby

Former names

CMC Drug Product Consulting ApS – now
CMC Drug Product Consulting IVS –
Natuzone IVS –

Similar companies in Hvidovre

Questions and answers about CMC Drug Product Consulting ApS

Has CMC Drug Product Consulting ApS gone bankrupt?

No, CMC Drug Product Consulting ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of CMC Drug Product Consulting ApS?

Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the auditor of CMC Drug Product Consulting ApS?

CMC Drug Product Consulting ApS most recently used MunkStrunge.

When was CMC Drug Product Consulting ApS founded?

CMC Drug Product Consulting ApS was founded on 26 July 2017.

What is the equity of CMC Drug Product Consulting ApS?

Equity was DKK 692k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.